<DOC>
	<DOCNO>NCT00077818</DOCNO>
	<brief_summary>The purpose study determine efficacy safety enoxaparin compare unfractionated heparin ( UFH ) patient diagnose Acute Coronary Syndrome ( ACS ) emergency department ( ED ) . Efficacy assess use composite score consist 30-day all-cause mortality , non-fatal myocardial infarction ( MI ) recurrent angina require revascularization .</brief_summary>
	<brief_title>Enoxaparin Versus Unfractionated Heparin Subjects Who Present Emergency Department With Acute Coronary Syndrome ( RESCUE )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>INCLUSION CRITERIA Rest angina last least 10 minute highly suggestive myocardial ischemia explain trauma obvious abnormality chest xray , occur within 24 hour randomization ; TIMI risk score great equal 4 ( qualitative test CKMB Troponin may utilize screening purpose ; however , quantitative test must still perform . ) EXCLUSION CRITERIA Increased bleed risk define follow : Ischemic stroke within last year Any previous hemorrhagic stroke , intracranial tumor , intracranial aneurysm Recent ( &lt; 1 month ) trauma major surgery ( include bypass surgery ) Active bleed ( minor skin abrasion ) Impaired hemostasis include one following : Known International Normalized Ratio ( INR ) &gt; 1.5 Past present bleeding disorder ( include congenital bleeding disorder von Willebrand 's disease hemophilia , acquire bleeding disorder , unexplained clinically significant bleed disorder ) Known history thrombocytopenia ( platelet count &lt; 100,000/mL ) History thrombocytopenia glycoprotein IIb/IIIa inhibitor therapy , heparin , enoxaparin Angina secondary cause : severe , uncontrolled hypertension ( systolic blood pressure &gt; 180 mm Hg despite treatment ) anemia valvular disease congenital heart disease hypertrophic cardiomyopathy restrictive constrictive cardiomyopathy thyrotoxicosis . Bundle branch block know old context angina . Undergone percutaneous coronary intervention ( PCI ) within past 24 hour . A known allergy heparin , low molecular weight heparin , pork pork product . Any contraindication treatment UFH LMWH . A recent ( &lt; 48 hour ) plan spinal/epidural anesthesia puncture . Thrombolytic therapy within precede 24 hour . Any clinically relevant serious disease , include severe liver disease renal failure [ creatinine clearance &lt; 30 mL/min ] , render implementation protocol interpretation study result difficult . Treatment investigational agent device within previous 30 day , plan use investigational drug device , previously enrol trial . Inability comply protocol ( e.g. , uncooperative attitude , inability return followup visit ) . Inability understand nature , scope , possible consequence study otherwise unable provide inform consent . A prosthetic heart valve</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>